Open AccessThe pharmacoeconomic analysis of the cost efficiency of trastuzumab in the adjuvant therapy of HER2 + early breast cancer
Author(s) -
N. Bezditko,
O.V. Muzhychuk
Publication year - 2019
Publication title -
klìnìčna farmacìâ
Language(s) - English
Resource type - Journals
eISSN - 2518-1572
pISSN - 1562-725X
DOI - 10.24959/cphj.19.1507
Subject(s) - trastuzumab , medicine , breast cancer , oncology , cancer , cost effectiveness , clinical trial , health care , adjuvant therapy , intensive care medicine , risk analysis (engineering) , economics , economic growth